{
  "meta": {
    "title": "Liver_Disorders",
    "url": "https://brainandscalpel.vercel.app/liver-disorders-d57d80f6.html",
    "scrapedAt": "2025-11-29T18:32:17.181Z"
  },
  "questions": [
    {
      "id": 14958,
      "choices": [
        {
          "id": 59792,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formation of sinusoids <em>&nbsp;</em></span></span></span></span></p>"
        },
        {
          "id": 59793,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin A storage </span></span></span></span></p>"
        },
        {
          "id": 59794,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases blood perfusion </span></span></span></span></p>"
        },
        {
          "id": 59795,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phagocytosis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Function of hepatic stellate cells is/are: </span></span></p>",
      "unique_key": "Q4902332",
      "question_audio": null,
      "question_video": null,
      "map_id": 32439,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Vitamin A storage </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>hepatic stellate cells </strong>(also called Ito cells) are of <strong>mesenchymal origin</strong>, found in <strong>space of Disse</strong>. The <strong>stellate cells </strong>play a role in the <strong>storage </strong>and <strong>metabolism of vitamin A </strong>and are <strong>transformed into collagen </strong>producing <strong>myofibroblasts </strong>when there is <strong>inflammation </strong>and <strong>cause fibrosis of liver</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hepatic stellate cells </strong>are primarily responsible for the <strong>storage and metabolism of vitamin A in the liver</strong>. They contain <strong>lipid droplets rich in retinyl esters</strong>, serving as the <strong>major reservoir for vitamin A </strong>in the <strong>body</strong>. During <strong>states of liver injury </strong>or <strong>inflammation</strong>, <strong>hepatic stellate cells </strong>can undergo <strong>activation </strong>and <strong>transform into myofibroblasts</strong>, leading to <strong>fibrosis</strong>. However, their primary function is the storage of vitamin A.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hepatic sinusoids </strong>are <strong>specialized blood vessels </strong>within the <strong>liver </strong>that <strong>facilitate exchange between the blood </strong>and <strong>hepatocytes</strong>. Sinusoid formation involves complex interactions between various cell types during liver development.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hepatic stellate cells </strong>do <strong>not directly regulate blood perfusion </strong>in the <strong>liver</strong>. <strong>Blood perfusion </strong>within the <strong>liver </strong>is primarily <strong>regulated by hepatic blood flow dynamics</strong>, which involve interactions between hepatic arteries, portal veins, and hepatic sinusoids. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phagocytic activity </strong>in the <strong>liver </strong>is primarily <strong>carried out by Kupffer cells</strong>, which are <strong>specialized macrophages </strong>located within the <strong>hepatic sinusoids</strong>. Kupffer cells play a crucial role in clearing pathogens, cellular debris, and foreign particles from the bloodstream, contributing to liver defense and immune function.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hepatic stellate cells </strong>have <strong>diverse functions</strong>, including their <strong>involvement in liver fibrosis</strong>, the <strong>primary function </strong>attributed to them is the <strong>storage and metabolism of vitamin A</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins&rsquo; 10th/ 824</span></span></strong></span></span></p>",
      "correct_choice_id": 59793,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14967,
      "choices": [
        {
          "id": 59828,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asymptomatic carrier </span></span></span></span></p>"
        },
        {
          "id": 59829,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic active carrier </span></span></span></span></p>"
        },
        {
          "id": 59830,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fulminant hepatitis B </span></span></span></span></p>"
        },
        {
          "id": 59831,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recovered from acute self-limited HBV</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After passing his physical exam, a young army recruit gives urine and blood samples for further testing. Serum analysis yields elevated ALT, HBsAg, Anti-HBc, HBeAg, and bilirubin. All other values are normal. Which of the following is the hepatitis B status of this recruit? </span></span></p>",
      "unique_key": "Q8509068",
      "question_audio": null,
      "question_video": null,
      "map_id": 32444,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Chronic active carrier </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presence of elevated ALT</strong>, <strong>HBsAg</strong>, <strong>anti-HBc</strong>, <strong>HBeAg</strong>, and <strong>bilirubin </strong>all point to <strong>active hepatitis B</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>asymptomatic carrier </strong>does <strong>not </strong>have <strong>ele&shy;vated ALT and bilirubin</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>absence of findings </strong>on <strong>physical examination rules out </strong>fulminant hepatitis B </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Recovery from acute self-limited HBV </strong>is asso&shy;ciated with the <strong>presence of anti-HBs </strong>and the <strong>decrease in HBsAg and HBeAg</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presence of elevated ALT</strong>, <strong>HBsAg, anti-HBc</strong>, <strong>HBeAg, </strong>and <strong>bilirubin </strong>are indicative of <strong>active hepatitis B infection</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/ 839</span></span></strong></span></span></p>",
      "correct_choice_id": 59829,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14955,
      "choices": [
        {
          "id": 59780,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dubin-Johnson syndrome </span></span></span></span></p>"
        },
        {
          "id": 59781,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rotor syndrome </span></span></span></span></p>"
        },
        {
          "id": 59782,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gilbert syndrome </span></span></span></span></p>"
        },
        {
          "id": 59783,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gall stones</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following condition is associated with unconjugated hyperbilirubinemia? </span></span><em>&nbsp;</em></p>",
      "unique_key": "Q5800156",
      "question_audio": null,
      "question_video": null,
      "map_id": 32436,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Gilbert syndrome </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Unconjugated hyperbilirubinemia </strong>is characterized by <strong>elevated levels of unconjugated </strong>(indirect) <strong>bilirubin </strong>in the <strong>blood</strong>. <strong>Gilbert syndrome </strong>is a common <strong>inherited condition </strong>associated with <strong>mild unconjugated hyperbilirubinemia</strong>. It results from a <strong>decreased activity </strong>of the <strong>enzyme UDP-glucuronosyltransferase</strong>, leading to <strong>impaired conjugation of bilirubin in the liver</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Dubin-Johnson syndrome:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">it is characterized by <strong>conjugated hyperbilirubinemia</strong>. It is a <strong>rare genetic disorder </strong>where there is <strong>impaired excretion </strong>of <strong>conjugated bilirubin </strong>from the liver.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Rotor syndrome:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">it is also associated with <strong>conjugated hyperbilirubinemia</strong>. It is a benign condition characterized by elevated levels of both conjugated and unconjugated bilirubin.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Gall stones:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; they can <strong>lead to obstructive jaundice</strong>, causing <strong>elevated levels of both conjugated </strong>and <strong>unconjugated bilirubin</strong>. However, the primary association is with conjugated hyperbilirubinemia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gilbert syndrome </strong>is a common <strong>inherited condition </strong>associated with <strong>unconjugated hyperbilirubinemia.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 853</span></span></strong></span></span></p>",
      "correct_choice_id": 59782,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14956,
      "choices": [
        {
          "id": 59784,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">G6PD deficiency&nbsp;<i>&nbsp;</i></span></p>"
        },
        {
          "id": 59785,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hemolytic anemia</span></p>"
        },
        {
          "id": 59786,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hereditary spherocytosis</span></p>"
        },
        {
          "id": 59787,
          "text": "<p><span style=\"font-size:12.0pt;\">Biliary cirrhosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient with unconjugated bilirubinemia has increased excretion of urobilinogen in his urine. This can be seen in all of the following conditions, except:</span></p>",
      "unique_key": "Q8264186",
      "question_audio": null,
      "question_video": null,
      "map_id": 32437,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D) Biliary cirrhosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Biliary cirrhosis </strong>primarily <strong>affects the conjugated bilirubin pathway</strong>, and it is associated with <strong>conjugated hyperbilirubinemia</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>G6PD deficiency</strong> can <strong>lead to hemolysis</strong>, resulting in <strong>increased unconjugated bilirubin production</strong>. Therefore, it is associated with increased urobilinogen excretion.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B: Hemolytic anemia,&nbsp;</strong>where <strong>red blood cells </strong>are <strong>destroyed prematurely</strong>, <strong>increase the production </strong>of <strong>unconjugated bilirubin</strong>. This can lead to increased urobilinogen in the urine.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C: Hereditary spherocytosis&nbsp;</strong>is a <strong>hemolytic disorder </strong>characterized by <strong>spherical-shaped red blood cells</strong>, leading to <strong>increased bilirubin production</strong>. It is associated with increased urobilinogen excretion.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Biliary cirrhosis </strong>is associated with <strong>conjugated hyperbilirubinemia</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EEwYoJr.png\" width=\"1338\" height=\"566\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 855</strong></span></p>",
      "correct_choice_id": 59787,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14957,
      "choices": [
        {
          "id": 59788,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is an increased rate of destruction of red blood cells </span></span></span></span></p>"
        },
        {
          "id": 59789,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The unconjugated bilirubin is trapped by the bile stone produced in the bile duct</span></span></span></span></p>"
        },
        {
          "id": 59790,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The conjugation process of bilirubin in liver remains operative without any interference</span></span></span></span></p>"
        },
        {
          "id": 59791,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The UDP glucuronyl transferase activity is increased manifold in obstructive jaundice </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In post-hepatic jaundice, the concentration of conjugated bilirubin in the blood is higher than that of unconjugated bilirubin because: </span></span><em>&nbsp;</em></p>",
      "unique_key": "Q6084160",
      "question_audio": null,
      "question_video": null,
      "map_id": 32438,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) The conjugation process of bilirubin in liver re&shy;mains operative without any interference</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>post-hepatic </strong>(obstructive) <strong>jaundice</strong>, the <strong>flow of bile is obstructed</strong>, leading to the <strong>accumulation of conjugated bilirubin </strong>in the <strong>blood</strong>. <strong>Conjugated bilirubin </strong>is <strong>water-soluble </strong>and can be <strong>excreted in bile</strong>. The <strong>liver&#39;s conjugation process </strong>continues to <strong>operate normally in obstructive jaundice</strong>, and there is no interference with the conjugation of bilirubin.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Increased destruction </strong>of <strong>red blood cells </strong>(hemolysis) primarily leads to <strong>unconjugated hyperbilirubinemia</strong>, not conjugated hyperbilirubinemia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bile stones </strong>(gallstones) can cause <strong>obstruction </strong>and may <strong>lead to obstructive jaundice</strong>, but the bilirubin trapped is primarily conjugated, not unconjugated.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>obstructive jaundice</strong>, there is <strong>no direct increase in UDP glucuronyl transferase activity</strong>. The elevated levels of conjugated bilirubin result from impaired excretion rather than increased conjugation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>post-hepatic jaundice</strong>, the <strong>concentration of conjugated bilirubin </strong>in the <strong>blood is higher </strong>than that of <strong>unconjugated bilirubin </strong>because</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> the <strong>flow of bile is obstructed</strong>, leading to the accumulation of conjugated bilirubin in the blood.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ </span></span></strong></span></span></p>",
      "correct_choice_id": 59790,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14960,
      "choices": [
        {
          "id": 59800,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Rotor’s syndrome</span></p>"
        },
        {
          "id": 59801,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Criggler Najjar syndrome</span></p>"
        },
        {
          "id": 59802,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Gilbert syndrome</span></p>"
        },
        {
          "id": 59803,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary spherocytosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following diseases is not a cause of indirect hyperbilirubinemia?&nbsp;</span><i>&nbsp;</i></p>",
      "unique_key": "Q9656122",
      "question_audio": null,
      "question_video": null,
      "map_id": 32440,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) Rotor’s syndrome</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Rotor’s syndrome </strong>is a <strong>rare benign condition </strong>characterized by <strong>elevated levels of conjugated bilirubin</strong>. It is a <strong>cause of direct hyperbilirubinemia</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B: Criggler Najjar syndrome&nbsp;</strong>is a <strong>hereditary disorder </strong>characterized by <strong>deficiency or absence of UDP-glucuronosyltransferase enzyme activity</strong>, leading to <strong>impaired conjugation of bilirubin</strong>. It is a cause of indirect hyperbilirubinemia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C: Gilbert syndrome&nbsp;</strong>is a <strong>common inherited disorder </strong>characterized by <strong>mild deficiency of UDP-glucuronosyltransferase enzyme activity</strong>, resulting in <strong>reduced conjugation of bilirubin</strong>. It is a cause of indirect hyperbilirubinemia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D: Hereditary spherocytosis&nbsp;</strong>is a <strong>hemolytic disorder </strong>characterized by <strong>spherical-shaped red blood cells</strong>. It can <strong>lead to increased production of unconjugated bilirubin </strong>due to <strong>premature destruction of red blood cells </strong>(hemolysis). Therefore, it is not a cause of indirect hyperbilirubinemia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Rotor’s syndrome </strong>is a cause of <strong>direct hyperbilirubinemia</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qLs1qmx.png\" width=\"1183\" height=\"639\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10th/ 853</strong></span></p>",
      "correct_choice_id": 59800,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14961,
      "choices": [
        {
          "id": 59804,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatitis B carrier </span></span></span></span></p>"
        },
        {
          "id": 59805,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recently infected with hepatitis B </span></span></span></span></p>"
        },
        {
          "id": 59806,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immunized against hepatitis B </span></span></span></span></p>"
        },
        {
          "id": 59807,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infected with hepatitis B and highly transmissible</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman Aishwarya goes to her gynecologist Dr. Raina Chawla for a pre-pregnancy examination. Routine prenatal laboratory testing demonstrates normal hematological profile with controlled sugar as well negative TORCH infections. She normal liver function tests with the following profile: HBsAg negative, anti- HBcAg (-), anti- HBeAg (-), HBV DNA polymerase (-) but anti- HBsAg is positive. Which of the following likely represents the status of the patient? </span></span></p>",
      "unique_key": "Q2091022",
      "question_audio": null,
      "question_video": null,
      "map_id": 32441,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Immunized against hepatitis B </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ms Aishwarya is <strong>positive </strong>only for the <strong>antibody to the hepatitis B antigen</strong>. This is suggestive of her <strong>being vacci&shy;nated </strong>for <strong>hepatitis B virus </strong>(HBV). The <strong>vaccine consists of recombinantly produced HBV surface antigen </strong>(HBsAg) alone and the <strong>antibodies to this protein provide immunity</strong>. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recently <strong>infected with hepatitis B </strong>In <strong>acute infection</strong>, we would expect to <strong>see HBsAg, </strong>and possibly <strong>IgM anti-HBc </strong>(indicating a recent infection). In this patient, <strong>HBsAg and anti-HBc are both negative</strong>, making recent infection unlikely.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Hepatitis B carrier:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This status would be indicated by the <strong>presence of hepatitis B surface antigen</strong> (HBsAg) in the <strong>serum for more than six months</strong>. A carrier is also often positive for hepatitis B e antigen (HBeAg) or has detectable levels of HBV DNA, reflecting ongoing replication of the virus. However, this patient is negative for HBsAg, HBeAg, and HBV DNA polymerase, so she is not a carrier.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Immunized against hepatitis B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presence of antibodies to HBsAg </strong>(anti-HBs) without the <strong>presence of HBsAg or anti-HBc </strong>suggests <strong>immunity from vaccination</strong>. This is because the hepatitis B vaccine contains HBsAg, which stimulates the production of anti-HBs without causing an infection.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Infected with hepatitis B and highly transmissible:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the patient were <strong>infected and highly infectious</strong>, we would expect to see <strong>positive HBeAg and HBV DNA polymerase </strong>since these are <strong>markers of high levels of viral replication </strong>and <strong>infectivity</strong>. However, this patient is negative for both.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presence of anti-HBsAg </strong>in the <strong>absence of HBsAg </strong>and other <strong>markers of infection </strong>indicates that the <strong>patient has been successfully immunized against hepatitis B. </strong>The hepatitis B vaccine induces the production of anti-HBs antibodies, which provide immunity to the virus.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/ 835</span></span></strong></span></span></p>",
      "correct_choice_id": 59806,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14963,
      "choices": [
        {
          "id": 59812,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Blood transfusion</span></p>"
        },
        {
          "id": 59813,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Heterosexual transmission</span></p>"
        },
        {
          "id": 59814,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Vertical transmission during childbirth</span></p>"
        },
        {
          "id": 59815,
          "text": "<p><span style=\"font-size:12.0pt;\">Needle stick injury</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An eminent hepatobiliary expert Dr. Sarin conducts a study in hepatitis B patients for which the patients are followed for almost a decade. Their detailed history regarding the mode of transmission of HBV is taken. A battery of tests including periodic serologic testing for HBs Ag, anti HBs and anti-HBc, and serum levels of bilirubin, SOT, SGPT, alkaline phosphatase, and prothrombin time is conducted. Dr. Sarin finds that a particular group of patients happen to be chronic carriers of HBV. This finding is most likely to be associated with which of the following modes of transmission of HBV?</span></p>",
      "unique_key": "Q1184560",
      "question_audio": null,
      "question_video": null,
      "map_id": 32442,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C) Vertical transmission during childbirth</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">This is the most <strong>common mode of transmission </strong>associated with the <strong>development of chronic HBV carriers</strong>. <strong>Infants infected </strong>at <strong>birth </strong>from their <strong>mothers have a high risk of becoming chronic carriers </strong>because their <strong>immune systems </strong>are <strong>not fully developed</strong>, which <strong>prevents the kind of immune response </strong>needed to clear the virus.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation</u>:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A: Blood transfusion:&nbsp;</strong>Though <strong>hepatitis B </strong>can be <strong>transmitted through blood transfusions</strong>, the risk is significantly <strong>reduced due to rigorous screening protocols </strong>for <strong>blood and blood products</strong>. Chronic carriage from this mode is less likely in the current era due to these safeguards.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B: Heterosexual transmission:&nbsp;Hepatitis B </strong>can be <strong>spread through sexual contact</strong>; however, <strong>chronic carrier status </strong>is <strong>less commonly associated </strong>with this <strong>mode of transmission </strong>compared to others, particularly vertical transmission during childbirth.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D: Needle stick injury:&nbsp;</strong>While <strong>hepatitis B </strong>can be <strong>transmitted via needle stick injuries</strong>, and the risk is higher compared to HIV and HCV, the development of chronic carrier status from this mode is less frequent than with vertical transmission.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Chronic carrier status of HBV </strong>is most closely associated with <strong>vertical transmission </strong>due to the <strong>lack of a mature immune response </strong>in <strong>newborns</strong>, which is necessary to <strong>clear the virus </strong>and <strong>prevent chronic infection</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Horizontal transmission</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Transmission of HBV <strong>between individuals other than mother-to-child at birth.</strong></span></li><li><span style=\"font-size:16px;\">Usually occurs <strong>after the neonatal period</strong>, typically in <strong>infancy or early childhood</strong>.</span></li><li><span style=\"font-size:16px;\">Mode: close contact, sharing toothbrushes, razors, minor cuts, sometimes bites.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QbK8CqN.png\" width=\"1401\" height=\"612\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10th/ 837</strong></span></p>",
      "correct_choice_id": 59814,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14965,
      "choices": [
        {
          "id": 59820,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Berry aneurysm </span></span></span></span></p>"
        },
        {
          "id": 59821,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coronary artery aneurysm </span></span></span></span></p>"
        },
        {
          "id": 59822,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyarteritis nodosa </span></span></span></span></p>"
        },
        {
          "id": 59823,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giant cell arteritis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old man Bholu presents to his physician with loss of appetite, nausea and vomiting, and fatigue. Laboratory examination confirms the diagnosis of hepatitis B, and the man becomes icteric 2 weeks later. This patient may also be particularly vulnerable to the development of which of the following disorders? </span></span></p>",
      "unique_key": "Q2042994",
      "question_audio": null,
      "question_video": null,
      "map_id": 32443,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Polyarteritis nodosa </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thirty percent of patients </strong>with <strong>polyarteritis nodosa </strong>have <strong>hepatitis B antigenemia</strong>. <strong>Polyarteritis </strong>is a <strong>systemic necrotizing vasculitis </strong>that can be <strong>difficult to diagnose</strong>, since the <strong>vascular involvement </strong>is typically <strong>widely scattered</strong>, and the <strong>specific symptoms </strong>depend on the <strong>specific vessels </strong>(small-to medium-sized arteries) involved. Patients typically <strong>present with low-grade fever</strong>, <strong>weakness</strong>, and <strong>weight loss</strong>. <strong>Abdominal pain</strong>, <strong>hematuria</strong>, <strong>renal failure</strong>, <strong>hypertension</strong>, and <strong>leukocytosis may occur</strong>. The disease is frequently fatal if untreated. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Berry aneurysm:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A berry aneurysm is typically associated with conditions like <strong>polycystic kidney disease </strong>and <strong>hypertension</strong>, and it predominantly <strong>affects the cerebral vasculature</strong>. It is not commonly linked to hepatitis B infection.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Coronary artery aneurysm</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This type of <strong>aneurysm </strong>is often associated with <strong>Kawasaki disease </strong>or <strong>atherosclerosis</strong>, and there is <strong>no direct link to hepatitis B infection </strong>for the development of coronary artery aneurysms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Giant cell arteritis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Giant cell arteritis typically <strong>affects the large and medium arteries of older adults</strong>, particularly the temporal arteries, and is not associated with hepatitis B infection.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is a <strong>well-established association between hepatitis B infection </strong>and the <strong>development of polyarteritis nodosa</strong>, a <strong>systemic necrotizing vasculitis </strong>that can <strong>affect various organ systems </strong>and can be <strong>fatal if untreated</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/ 510</span></span></strong></span></span></p>",
      "correct_choice_id": 59822,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14971,
      "choices": [
        {
          "id": 59844,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolysis </span></span></span></span></p>"
        },
        {
          "id": 59845,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated liver enzymes </span></span></span></span></p>"
        },
        {
          "id": 59846,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombocytopenia </span></span></span></span></p>"
        },
        {
          "id": 59847,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retroplacental hemorrhage</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a part of HELLP syndrome? </span></span></p>",
      "unique_key": "Q2589441",
      "question_audio": null,
      "question_video": null,
      "map_id": 32445,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Retroplacental hemorrhage </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>subclinical hepatic disease </strong>may be the <strong>primary manifestation of preeclampsia</strong>, as part of a <strong>syndrome of <em>h</em>emolysis</strong>, <strong><em>e</em>levated <em>l</em>iver enzymes</strong>, and <strong><em>l</em>ow <em>p</em>latelets</strong>, dubbed the <strong><em>HELLP syndrome</em>.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Retroplacental hemorrhage </strong>is <strong>not a part of HELLP syndrome</strong>. It refers to <strong>bleeding that occurs behind the placenta</strong>, which is often associated with conditions like placental abruption but not directly related to HELLP syndrome.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Hemolysis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a <strong>component of HELLP syndrome</strong>. It can be confirmed by laboratory findings such as anemia, elevated lactate dehydrogenase (LDH), and the presence of schistocytes on peripheral smear.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Elevated liver enzymes:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated liver enzymes, including <strong>aspartate aminotransferase </strong>(AST) and <strong>alanine aminotransferase </strong>(ALT), are represented by the <strong>EL in HELLP</strong>. They reflect hepatic injury, which is part of this syndrome.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Thrombocytopenia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>LP in HELLP </strong>stands for <strong>low platelets</strong>, this can result in an increased risk of bleeding.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>HELLP syndrome </strong>is characterized by <strong>Hemolysis, Elevated Liver enzymes</strong>, and <strong>Low Platelet count</strong>, and does <strong>not </strong>include <strong>retroplacental hemorrhage </strong>as a component.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/ 870</span></span></strong></span></span></p>",
      "correct_choice_id": 59847,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14975,
      "choices": [
        {
          "id": 59860,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgM anti HBc </span></span></span></span></p>"
        },
        {
          "id": 59861,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgG anti HBc </span></span></span></span></p>"
        },
        {
          "id": 59862,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgG anti HBs </span></span></span></span></p>"
        },
        {
          "id": 59863,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgM anti Hbe</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A nurse sustains a needle prick injury while caring for a patient with suspected hepatitis B infection. Which of the following suggests active phase of hepatitis?</span></span></p>",
      "unique_key": "Q7487818",
      "question_audio": null,
      "question_video": null,
      "map_id": 32446,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) IgM anti HBc </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgM anti-HBc antibody </span></span></em></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">becomes <strong>detectable in serum <em>shortly before&nbsp;</em></strong>the <strong>onset of symptoms</strong>, <strong>concurrent </strong>with the <strong><em>onset of elevated serum aminotransferase levels </em></strong>(indicative of hepato&shy;cyte destruction).</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presence of IgM antibody </strong>to <strong>hepatitis B core antigen </strong>(anti-HBc) is indicative of an <strong>acute or recent infection</strong>. <strong>IgM anti-HBc </strong>becomes <strong>detectable shortly before the onset of symptoms </strong>and coincides with <strong>liver cell damage</strong>, as indicated by <strong>elevated serum aminotransferase levels</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: IgG anti-HBc:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgG antibody </strong>to <strong>HBcAg </strong>indicates a <strong>past or chronic infection</strong>. It <strong>remains positive after </strong>an <strong>acute infection </strong>has been resolved and can also be present in chronic carriers of hepatitis B.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: IgG anti-HBs:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presence of IgG antibodies </strong>to <strong>hepatitis B surface antigen </strong>(anti-HBs) suggests <strong>immunity to hepatitis B</strong>, which can <strong>occur through vaccination </strong>or recovery from past infection. It does not indicate an active phase of infection.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: IgM anti-HBe:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgM antibody </strong>to <strong>hepatitis B e antigen </strong>(anti-HBe) is <strong>not a standard marker </strong>for the <strong>active phase of hepatitis</strong>. Anti-HBe generally indicates a lower level of viral replication and infectivity.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgM anti HBc&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>antibody </strong>becomes <strong>detectable </strong>shortly <strong>before the onset of symptoms </strong>and is a <strong>marker of the active phase of hepatitis B infection</strong>, reflecting recent exposure and active viral replication.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 833</span></span></strong></span></span></p>",
      "correct_choice_id": 59860,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14977,
      "choices": [
        {
          "id": 59868,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hepatitis A</span></p>"
        },
        {
          "id": 59869,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hepatitis B</span></p>"
        },
        {
          "id": 59870,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hepatitis C</span></p>"
        },
        {
          "id": 59871,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis E</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 32-year-old male presents to the clinic with complaints of fatigue, dark urine, and yellow discoloration of the skin and eyes for the past week. He reports recent travel to a developing country and consuming local food and water. Physical examination reveals jaundice. Laboratory tests show elevated serum bilirubin levels, particularly the unconjugated fraction. Which hepatitis virus is most likely responsible for the maximum ground glass appearance change in this patient?</span></p>",
      "unique_key": "Q3598056",
      "question_audio": null,
      "question_video": null,
      "map_id": 32427,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. B) Hep B</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">In the context of <strong>liver histology</strong>, <strong>ground glass hepatocytes </strong>are a characteristic finding in <strong>hepatitis B infection</strong>. These <strong>hepatocytes </strong>exhibit a <i><strong>granular or ground glass appearance</strong></i> due to the <strong>accumulation of viral particles</strong>, particularly the <strong>hepatitis B surface antigen (HBsAg)</strong>, in the <strong>cytoplasm</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Hepatitis B virus </strong>is known for the <strong>\"ground glass\" appearance </strong>of <strong>hepatocytes under the microscope. </strong>This is due to the <strong>accumulation of viral surface antigens </strong>in the <strong>endoplasmic reticulum of infected cells </strong>and is a hallmark of HBV infection.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation</u></strong>:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A: Hepatitis A&nbsp;virus </strong>can cause <strong>acute liver disease</strong>, but it is <strong>not </strong>typically associated with <strong>ground glass hepatocyte appearance</strong>. It is characterized by a self-limiting course and does not lead to chronic liver disease.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:&nbsp;</strong>While <strong>hepatitis C</strong> can <strong>lead to chronic liver disease </strong>and eventually to <strong>cirrhosis and hepatocellular carcinoma</strong>, it is not particularly associated with ground glass hepatocyte appearance. It typically shows more of a lymphocytic response and steatosis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D: Hepatitis E&nbsp;virus </strong>is another cause of <strong>acute viral hepatitis </strong>and is known for its <strong>prevalence in developing countries </strong>through <strong>contaminated water</strong>. However, it does not cause the ground glass hepatocyte appearance that is seen with hepatitis B.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ground glass hepatocyte appearance </strong>is characteristic of <strong>hepatitis B infection </strong>due to the <strong>cytoplasmic accumulation of hepatitis B surface antigen </strong>(HBsAg).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Summary Table – Histologic Hallmarks of Hepatitis Viruses</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_IkKqBZW.png\" width=\"1149\" height=\"377\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10th/ 834</strong></span></p>",
      "correct_choice_id": 59869,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14981,
      "choices": [
        {
          "id": 59884,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Infants having vertical transmission develop chronic infections</span></p>"
        },
        {
          "id": 59885,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">HBc Ag in serum is indicative of active infection</span></p>"
        },
        {
          "id": 59886,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Can cause hepatocellular cancer</span></p>"
        },
        {
          "id": 59887,
          "text": "<p><span style=\"font-size:12.0pt;\">Interferons are used for treatment</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The following are true attributes of hepatitis B infection <i>except</i>:</span></p>",
      "unique_key": "Q4808408",
      "question_audio": null,
      "question_video": null,
      "map_id": 32428,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. B) HBc Ag in serum is indicative of active infection</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>HBe Ag </strong>and <strong>not HBc Ag in serum </strong>is indicative of <strong>active infection</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Persistence of HBeAg </strong>is an important <strong>indicator of continued viral replication</strong>, infectivity, and probable progression to chronic hepatitis.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Hepatitis B core antigen </strong>(HBcAg) is <strong>not </strong>typically found in the <strong>serum due to the antigen's strong association with liver tissue</strong>. The <strong>presence of antibodies against HBcAg </strong>(anti-HBc) indicates <strong>past or ongoing infection</strong>, but HBcAg itself is usually not detectable in the blood.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation</u>:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:&nbsp;Infants infected </strong>with the <strong>hepatitis B virus </strong>(HBV) at <strong>birth</strong>, especially from <strong>mothers with high viral loads</strong>, have a <strong>high risk of developing chronic infections </strong>because their immune systems are not fully developed to clear the virus.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:&nbsp;Chronic HBV infection </strong>is a known <strong>risk factor for hepatocellular carcinoma </strong>(HCC). The virus can integrate into the host genome and lead to mutations that contribute to oncogenesis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D:&nbsp;Interferons</strong>, specifically <strong>pegylated interferon</strong>, have been <strong>used in the treatment of chronic hepatitis B</strong>. They work by modulating the immune response to help control or eliminate the virus.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>HBcAg </strong>is <strong>typically not found in the serum</strong>; its <strong>antibodies </strong>indicate <strong>past or ongoing infection. </strong>HBeAg is a better indicator of active replication and infectivity of hepatitis B.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Hepatitis B Virus Serologic Markers</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_yGVMYRz.png\" width=\"1355\" height=\"820\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10th 833</strong></span></p>",
      "correct_choice_id": 59885,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14984,
      "choices": [
        {
          "id": 59896,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vimentin </span></span></span></span></p>"
        },
        {
          "id": 59897,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytokeratin </span></span></span></span></p>"
        },
        {
          "id": 59898,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Keratin</span></span></span></span></p>"
        },
        {
          "id": 59899,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Collagen</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man with a history of chronic alcohol abuse presents with abdominal pain and hepatomegaly. Liver biopsy reveals abnormal intracellular inclusions in hepatocytes. Immunohistochemical analysis demonstrates the presence of intermediate filaments. Which protein is the major component of these inclusions?</span></span></p>",
      "unique_key": "Q9543095",
      "question_audio": null,
      "question_video": null,
      "map_id": 32429,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Cytokeratin </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><strong>Option B:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mallory bodies </strong>are <strong>visible as eosinophilic cytoplasmic clumps in hepatocytes</strong>. They are <strong>composed of tangled skeins of cytokeratin intermediate filaments </strong>such as <strong>cytokeratin 8 </strong>and <strong>18</strong>, in complex with other proteins such as ubiquitin. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-124753.png\" style=\"height:136px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cytokeratins </strong>are <strong>intermediate filament proteins </strong>found in <strong>epithelial cells</strong>. The <strong>intracellular inclusions </strong>seen in <strong>hepatocytes</strong>, known as <strong>Mallory bodies</strong>, are composed <strong>primarily of cytokeratin, </strong>particularly <strong>cytokeratin 8 and 18</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Vimentin&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>intermediate filament protein </strong>found in <strong>mesenchymal cells </strong>and is not typically associated with hepatocyte inclusions. It&#39;s more commonly related to cells of mesenchymal origin.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Keratins&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are a <strong>broader family </strong>of <strong>fibrous structural proteins</strong>; <strong>cytokeratins </strong>are a <strong>subtype found in epithelial cells</strong>. In the context of liver pathology, it is more accurate to specify cytokeratins as the component of the inclusions.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Collagen&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>structural protein </strong>found in <strong>connective tissues</strong>, such as <strong>tendons and ligaments</strong>, and is not involved in the formation of Mallory bodies within hepatocytes.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mallory bodies</strong>, which are <strong>abnormal intracellular inclusions </strong>found in <strong>hepatocytes</strong>, especially in conditions like <strong>alcoholic liver disease</strong>, are composed predominantly of <strong>cytokeratin intermediate filaments </strong>(CK 8 and 18).</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th 843</span></span></strong></span></span></p>",
      "correct_choice_id": 59897,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14986,
      "choices": [
        {
          "id": 59904,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Alcoholic liver disease</span></p>"
        },
        {
          "id": 59905,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Primary biliary cirrhosis</span></p>"
        },
        {
          "id": 59906,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Secondary biliary cirrhosis</span></p>"
        },
        {
          "id": 59907,
          "text": "<p><span style=\"font-size:12.0pt;\">Indian childhood cirrhosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is not associated with Mallory hyaline bodies?</span></p>",
      "unique_key": "Q7964942",
      "question_audio": null,
      "question_video": null,
      "map_id": 32430,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C) Secondary biliary cirrhosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Mallory bodies</strong>, also known as <strong>Mallory hyaline bodies </strong>or <strong>Mallory-Denk bodies</strong>, are <strong>abnormal intracellular inclusions </strong>found in <strong>hepatocytes</strong>. These structures are associated with <strong>various liver diseases</strong>, particularly those involving <strong>chronic hepatocellular injury</strong>. They are remembered as (New Indian Fine WATCH)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Non alcoholic fatty liver disease; NAFLD&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Indian childhood cirrhosis</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Focal nodular hyperplasia</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Wilson’s Disease</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Alcoholic liver disease, α-1 AT def.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Tumor (HCC)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Cholestasis (due to primary biliary cirrhosis)</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Mallory-denk bodies </strong>(made up keratin 8 and 18)<strong> </strong>are associated with <strong>various liver diseases</strong>, particularly those involving <strong>chronic hepatocellular injury</strong>, but are <strong>not </strong>typically found in <strong>secondary biliary cirrhosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 843</strong></span></p>",
      "correct_choice_id": 59906,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15015,
      "choices": [
        {
          "id": 60020,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Black pigment stones </span></span></span></span></p>"
        },
        {
          "id": 60021,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brown pigment stones </span></span></span></span></p>"
        },
        {
          "id": 60022,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biliary sludge </span></span></span></span></p>"
        },
        {
          "id": 60023,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phospholipid stones</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male film actor Sallu Kahn looses weight rap&shy;idly for one of his forthcoming films. He experiences occa&shy;sional abdominal discomfort few days after that and guided by his physician, he undergoes a radiological scan (HIDA scan) is shown to have slow and incomplete gallbladder emptying in response to cholecystokinin stimulation. This patient is likely to develop which of the following? </span></span></span></span></p>",
      "unique_key": "Q3414100",
      "question_audio": null,
      "question_video": null,
      "map_id": 32431,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Biliary sludge </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The demonstration of slow or incomplete gallbladder emp&shy;tying in response to cholecystokinin stimulation is called gallbladder hypomotility. This is usually associated with <strong><em>risk factors </em></strong>like <strong><em>pregnancy, rapid weight loss prolonged use of total parenteral nutrition or octreotide, and high spinal cord injuries</em></strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gallbladder hypomotility frequently results in the forma&shy;tion of biliary sludge, which results from bile precipitation. Biliary sludge typically contains cholesterol monohydrate crystals, calcium bilirubinate, and mucus and is a known precursor to stone formation. Complications such as acute cholecystitis occur in up to 20% of patients with biliary sludge. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Brown pigment </strong>stones are most likely to arise in cases of <strong>biliary tract infection</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Black pigment stones </strong>are most likely to arise in cases of <strong>intravascular hemolysis. </strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gallstones <strong>do not </strong>typically <strong><em>contain phospho&shy;lipid&nbsp;</em></strong>as a primary ingredient. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rapid weight loss </strong>can lead to <strong>gallbladder hypomotility</strong>, resulting in the <strong>formation of biliary sludge</strong>, which is a <strong>mixture of cholesterol crystals</strong>, <strong>calcium bilirubinate</strong>, and <strong>mucus </strong>that can <strong>precede stone formation</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th 871</span></span></strong></span></span></p>",
      "correct_choice_id": 60022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15019,
      "choices": [
        {
          "id": 60036,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary biliary cirrhosis </span></span></span></span></p>"
        },
        {
          "id": 60037,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary sclerosing cholangitis </span></span></span></span></p>"
        },
        {
          "id": 60038,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extrahepatic biliary fibrosis </span></span></span></span></p>"
        },
        {
          "id": 60039,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital hepatic fibrosis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 38-year-old patient presents with recurrent episodes of jaundice and pruritus. Liver biopsy reveals characteristic &quot;onion skin fibrosis&quot; around the bile ducts. Laboratory tests show elevated alkaline phosphatase levels. Which of the following conditions is most likely associated with the histological finding described?</span></span></p>",
      "unique_key": "Q1972053",
      "question_audio": null,
      "question_video": null,
      "map_id": 32432,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Primary sclerosing cholangitis </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&quot;Onion skin fibrosis&quot; </strong>refers to a characteristic <strong>histological finding in primary sclerosing cholangitis</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Primary sclerosing cholangitis </strong>is a <strong>chronic, progressive cholestatic liver disease </strong>characterized by&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>inflammation </strong>and <strong>fibrosis of the intrahepatic </strong>and <strong>extrahepatic bile ducts</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Primary biliary cirrhosis </strong>is a <strong>distinct autoimmune liver disease </strong>characterized by the <strong>destruction of small bile ducts </strong>within the <strong>liver</strong>. <strong>&quot;Onion skin fibrosis</strong>&quot; is <strong>not a typical histological finding </strong>in <strong>primary biliary cirrhosis</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Extrahepatic biliary fibrosis</strong>: This term is nonspecific and not commonly used as a diagnosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Congenital hepatic fibrosis </strong>is a <strong>developmental disorder of the liver </strong>and is not associated with onion skin fibrosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary sclerosing cholangitis&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>associated with characteristic &quot;onion skin fibrosis</strong>&quot; <strong>around bile ducts </strong>and <strong>elevated alkaline phosphatase levels</strong>, reflecting bile duct inflammation and fibrosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th 861</span></span></strong></span></span></p>",
      "correct_choice_id": 60037,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15022,
      "choices": [
        {
          "id": 60048,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wilson&rsquo;s disease </span></span></span></span></p>"
        },
        {
          "id": 60049,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha 1 antitrypsin deficiency </span></span></span></span></p>"
        },
        {
          "id": 60050,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemochromatosis </span></span></span></span></p>"
        },
        {
          "id": 60051,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary biliary cirrhosis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old patient presents with fatigue, hepatomegaly, and neurological symptoms such as tremors and dysarthria. Ophthalmic examination reveals a brownish ring around the cornea. Laboratory tests show elevated urinary copper levels and decreased ceruloplasmin levels. Which of the following conditions is most likely responsible for the observed ophthalmic finding in this patient?</span></span></p>",
      "unique_key": "Q5957769",
      "question_audio": null,
      "question_video": null,
      "map_id": 32433,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Wilson&rsquo;s disease</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&quot;Kayser-Fleischer ring&quot; </strong>is a <strong>brownish ring of copper deposits </strong>that can be <strong>observed in the cornea of the eye</strong>. This <strong>ring is a characteristic finding in Wilson&#39;s disease</strong>, an <strong>inherited disorder </strong>of <strong>copper metabolism</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wilson&#39;s disease </strong>is an <strong>autosomal recessive disorder </strong>of <strong>copper metabolism </strong>that leads to <strong>copper accumulation in various tissues</strong>, including the <strong>liver and brain</strong>. The <strong>Kayser-Fleischer ring</strong>, a <strong>brownish or greenish ring </strong>around the <strong>cornea due to copper deposition</strong>, is a hallmark of this condition.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Alpha-1 antitrypsin deficiency:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha-1 antitrypsin deficiency is a <strong>genetic condition </strong>that can <strong>lead to liver and lung disease </strong>due to the <strong>accumulation of abnormal alpha-1 antitrypsin protein </strong>in the <strong>hepatocytes</strong>. It does not cause the Kayser-Fleischer ring.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Hemochromatosis:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemochromatosis is a <strong>hereditary condition </strong>characterized by <strong>excessive iron accumulation </strong>in various <strong>organs </strong>but does not lead to the formation of a Kayser-Fleischer ring.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Primary biliary cirrhosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary biliary cirrhosis is an <strong>autoimmune liver disease </strong>characterized by the <strong>destruction of intrahepatic bile ducts</strong>. While it may lead to cirrhosis and associated symptoms, it does not cause the ophthalmic findings seen in Wilson&rsquo;s disease.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presence of a Kayser-Fleischer ring</strong>, <strong>neurological symptoms</strong>, <strong>elevated urinary copper levels</strong>, and <strong>decreased ceruloplasmin </strong>are all diagnostic of <strong>Wilson&#39;s disease</strong>, a disorder of copper metabolism.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> /850 </span></span></strong></span></span></p>",
      "correct_choice_id": 60048,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15023,
      "choices": [
        {
          "id": 60052,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Criggler Najjar syndrome type I </span></span></span></span></p>"
        },
        {
          "id": 60053,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Criggler Najjar syndrome type II </span></span></span></span></p>"
        },
        {
          "id": 60054,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dubin Johnson syndrome </span></span></span></span></p>"
        },
        {
          "id": 60055,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rotor syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old patient presents with persistent jaundice and darkly pigmented liver tissue observed on imaging studies. Laboratory tests reveal elevated levels of conjugated bilirubin, and liver biopsy shows pigmented granules within hepatocytes. Genetic testing reveals a mutation in the MRP2 gene. Which of the following liver disorders is most likely associated with the observed findings in this patient?</span></span></p>",
      "unique_key": "Q8341736",
      "question_audio": null,
      "question_video": null,
      "map_id": 32434,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Dubin Johnson syndrome </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dubin-Johnson syndrome&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>autosomal recessive </strong>disorder leading to impaired biliary excretion of bilirubin glucuronides due to mutation in <strong>canalicular multidrug resistance protein 2 (MRP2)</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The l<strong>iver in Dubin Johnson syndrome </strong>appears <strong>darkly pigmented </strong>due to the <strong>accumulation of brown-black melanin-like pigment </strong>in the <strong>hepatocytes</strong>, giving it a distinctive appearance. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Crigler Najjar syndrome type I </strong>is characterized by <strong>severe unconjugated hyperbilirubinemia </strong>due to a deficiency of UDP-glucuronosyltransferase enzyme activity.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Crigler Najjar syndrome type II </strong>is also characterized by <strong>unconjugated hyperbilirubinemia</strong>, but it is less severe than type I. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rotor syndrome </strong>is another <strong>rare disorder </strong>characterized by <strong>mild conjugated hyperbilirubinemia. </strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dubin-Johnson syndrome </strong>is characterized by <strong>conjugated hyperbilirubinemia </strong>and <strong>darkly pigmented liver </strong>due to a <strong>mutation in the MRP2 gene</strong>, leading to <strong>impaired excretion of bilirubin glucuronides.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th 856</span></span></strong></span></span></p>",
      "correct_choice_id": 60054,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16225,
      "choices": [
        {
          "id": 64860,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased insulin release</span></span></span></span></p>"
        },
        {
          "id": 64861,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steatosis</span></span></span></span></p>"
        },
        {
          "id": 64862,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatocyte dysfunction</span></span></span></span></p>"
        },
        {
          "id": 64863,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased &lsquo;C&rsquo; peptide level</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the primary contributor to insulin resistance in liver disease?</span></span></p>",
      "unique_key": "Q6672051",
      "question_audio": null,
      "question_video": null,
      "map_id": 32435,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Steatosis </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>accumulation of fat in the liver</strong>, or <strong>hepatic steatosis</strong>, is closely associated with <strong>insulin resistance</strong>. It <strong>impairs the liver&#39;s response </strong>to <strong>insulin</strong>, particularly affecting the <strong>inhibition of gluconeogenesis </strong>and <strong>increasing insulin resistance </strong>in <strong>peripheral tissues</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Decreased insulin release:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This refers to a <strong>problem with insulin secretion </strong>from the <strong>pancreas</strong>, not resistance at the level of hepatic or peripheral tissues and does not directly relate to liver disease.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hepatocyte dysfunction:</strong> While <strong>hepatocyte dysfunction </strong>can contribute to <strong>metabolic disturbances</strong>, it is a broader term that includes various liver impairments, not specific to insulin resistance.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased &lsquo;C&rsquo; peptide level:</strong> <strong>C-peptide </strong>is a <strong>byproduct of insulin production</strong>. <strong>Lower levels </strong>may indicate <strong>reduced insulin secretion </strong>but are not a direct cause of insulin resistance in the liver.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hepatic steatosis</strong>, or <strong>fatty liver disease</strong>, is a significant <strong>contributor to insulin resistance</strong>, which <strong>impairs both the liver&#39;s response </strong>to <strong>insulin </strong>and the <strong>peripheral action of insulin</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbin 10th/ 1140, Joslin&rsquo;s Diabetes Mellitus 14/e p436</span></span></strong></span></span></p>",
      "correct_choice_id": 64861,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}